ADVIA CENTAUR ANTI-HBS (AHBS)

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P030029 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for adding quantitative determination of total antibodies to hepatitis b surface antigen in human adult, adolescent, and pediatric serum or plasma to the intended use. The device, as modified, will be marketed under the trade name advia® centaur anti-hbs(ahbs) assay on centaur cp and is indicated for:advia® centaur anti-hbs (ahbs) assay on the centaur cp analyzer:the advia centaur anti-hbs assay is an in vitro diagnostic immunoassay for the qualitative and quantitative determination of total antibodies to hepatitis b surfaceantigen in human adult, adolescent, and pediatric serum or plasma (edta or heparinized) using the advia centaur cp system. The assay results may be used as an aid in thedetermination of susceptibility to hepatitis b virus (hbv) infection in individuals prior toor following hbv vaccination or where vaccination status is unknown. Assay results maybe used with other hbv serological markers for the laboratory diagnosis of hbv diseaseassociated with hbv infection. A reactive assay result will allow a differential diagnosis in individuals displaying signs and symptoms of hepatitis in whom etiology is unknown.

DeviceADVIA CENTAUR ANTI-HBS (AHBS)
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received2009-09-28
Decision Date2010-09-01
PMAP030029
SupplementS009
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032

Supplemental Filings

Supplement NumberDateSupplement Type
P030029Original Filing
S013 2012-03-26 Normal 180 Day Track No User Fee
S012 2011-02-16 30-day Notice
S011 2010-09-29 30-day Notice
S010
S009 2009-09-28 Normal 180 Day Track
S008 2009-08-21 30-day Notice
S007 2009-05-18 Normal 180 Day Track
S006 2009-03-31 Normal 180 Day Track
S005 2009-03-03 Normal 180 Day Track No User Fee
S004 2008-09-18 Normal 180 Day Track
S003 2008-08-11 Normal 180 Day Track
S002
S001 2007-03-14 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00630414471860 P030029 000
00630414471914 P030029 003

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.